Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Dimpal Nyayanit"'
Autor:
Pragya Yadav, Sreelekshmy Mohandas, Prasad Sarkale, Dimpal Nyayanit, Anita Shete, Rima Sahay, Varsha Potdar, Shrikant Baradkar, Nivedita Gupta, Gajanan Sapkal, Priya Abraham, Samiran Panda, Balram Bhargava
Publikováno v:
Journal of Infection and Public Health, Vol 15, Iss 2, Pp 164-171 (2022)
Background: Considering the potential threat from emerging Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2) variants and the rising COVID-19 cases, SARS-CoV-2 genomic surveillance is ongoing in India. We report herewith the isolation of
Externí odkaz:
https://doaj.org/article/78e313350512493dabe271266b9aee46
Autor:
Pragya D. Yadav, Raches Ella, Sanjay Kumar, Dilip R. Patil, Sreelekshmy Mohandas, Anita M. Shete, Krishna M. Vadrevu, Gaurav Bhati, Gajanan Sapkal, Himanshu Kaushal, Savita Patil, Rajlaxmi Jain, Gururaj Deshpande, Nivedita Gupta, Kshitij Agarwal, Mangesh Gokhale, Basavaraj Mathapati, Siddhanath Metkari, Chandrashekhar Mote, Dimpal Nyayanit, Deepak Y. Patil, B. S. Sai Prasad, Annasaheb Suryawanshi, Manoj Kadam, Abhimanyu Kumar, Sachin Daigude, Sanjay Gopale, Triparna Majumdar, Deepak Mali, Prasad Sarkale, Shreekant Baradkar, Pranita Gawande, Yash Joshi, Sidharam Fulari, Hitesh Dighe, Sharda Sharma, Rashmi Gunjikar, Abhinendra Kumar, Kaumudi Kalele, Vellimedu K. Srinivas, Raman R. Gangakhedkar, Krishna M. Ella, Priya Abraham, Samiran Panda, Balram Bhargava
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-11 (2021)
SARS-CoV-2 vaccines are needed to fight the pandemic. Here, authors show protective efficacy and immunogenicity of the inactivated SARS-CoV-2 vaccine BBV152 in rhesus macaques. This vaccine is currently in clinical development.
Externí odkaz:
https://doaj.org/article/31d3828a5c414597afab7a582efa0951
Autor:
Sreelekshmy Mohandas, Pragya D. Yadav, Anita Shete-Aich, Priya Abraham, Krishna Mohan Vadrevu, Gajanan Sapkal, Chandrashekhar Mote, Dimpal Nyayanit, Nivedita Gupta, Vellimedu Kannappa Srinivas, Manoj Kadam, Abhimanyu Kumar, Triparna Majumdar, Rajlaxmi Jain, Gururaj Deshpande, Savita Patil, Prasad Sarkale, Deepak Patil, Raches Ella, Sai D. Prasad, Sharda Sharma, Krishna M. Ella, Samiran Panda, Balram Bhargava
Publikováno v:
iScience, Vol 24, Iss 2, Pp 102054- (2021)
Summary: The availability of a safe and effective vaccine would be the eventual measure to deal with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) threat. Here, we have assessed the immunogenicity and protective efficacy of inactivated
Externí odkaz:
https://doaj.org/article/ac9a4f3849b545bf9a8f7cf134470233
Autor:
Sreelekshmy Mohandas, Pragya D. Yadav, Anita Shete, Dimpal Nyayanit, Rajlaxmi Jain, Gajanan Sapkal, Chandrashekhar Mote
Publikováno v:
Viruses, Vol 14, Iss 3, p 596 (2022)
The Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Delta variant has evolved to become the dominant SARS-CoV-2 lineage with multiple sub-lineages and there are also reports of re-infections caused by this variant. We studied the disease
Externí odkaz:
https://doaj.org/article/1bc0364d47114730b5deef69d62e3724
Autor:
Sreelekshmy Mohandas, Pragya Dhruv Yadav, Anita Shete, Dimpal Nyayanit, Gajanan Sapkal, Kavita Lole, Nivedita Gupta
Publikováno v:
Viruses, Vol 13, Iss 9, p 1773 (2021)
B.1.617 is becoming a dominant Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) lineage worldwide with many sublineages, of which B.1.617.2 is designated as a variant of concern. The pathogenicity of B.1.617.2 (Delta) and B.1.617.3 lineag
Externí odkaz:
https://doaj.org/article/c650ca2143784cfd82492ff494d28348
Autor:
Pragya D. Yadav, Sanjay Kumar, Kshitij Agarwal, Mukul Jain, Dilip R. Patil, Kapil Maithal, Basavaraj Mathapati, Suresh Giri, Sreelekshmy Mohandas, Anita Shete, Gajanan Sapkal, Deepak Y. Patil, Ayan Dey, Harish Chandra, Gururaj Deshpande, Nivedita Gupta, Priya Abraham, Himanshu Kaushal, Rima R. Sahay, Anuradha Tripathy, Dimpal Nyayanit, Rajlaxmi Jain, Abhimanyu Kumar, Prasad Sarkale, Shreekant Baradkar, Chozhavel Rajanathan, Hari Prasad Raju, Satish Patel, Niraj Shah, Pankaj Dwivedi, Dharmendra Singh
Publikováno v:
Journal of Medical Virology. 95
Autor:
PragyaD Yadav, Varsha Potdar, SarahS Cherian, GururajRao Deshpande, PadinjaremattathilThankappan Ullas, ManoharLal Choudhary, Rohan Gughe, Veena Vipat, Sheetal Jadhav, Savita Patil, Dimpal Nyayanit, Triparna Majumdar, Atul Walimbe, Shivshankar Gaikwad, Hitesh Dighe, Anita Shete-Aich, Sreelekshmy Mohandas, Deepika Chowdhury, Gajanan Sapkal, Atanu Basu, Nivedita Gupta, RamanR Gangakhedkar, Sidhartha Giri, Lalit Dar, Amita Jain, Bharati Malhotra, Priya Abraham, null NIC Team
Publikováno v:
Indian Journal of Medical Research, Vol 151, Iss 2, Pp 255-260 (2020)
The Indian Journal of Medical Research
The Indian Journal of Medical Research
Autor:
Yogesh K Gurav, Kalichamy Alagarasu, Pragya D Yadav, Gajanan Sapkal, Mangesh Gokhale, Deepti Parashar, Ujwala Jadhav, Minal Bote, Mahadeo Kakade, Dimpal Nyayanit, Abhinendra Kumar, Gururaj Rao Deshpande, Sarah Cherian, Pradip S Awate, Priya Abraham
Publikováno v:
Transactions of the Royal Society of Tropical Medicine and Hygiene. 116(10)
Background In July 2021, an outbreak of chikungunya virus (CHIKV) was reported in a rural region of Maharashtra state, India. Methods Serum samples of symptomatic cases (n=33) were screened for dengue virus (DENV), CHIKV and Zika virus (ZIKV) by mole
Autor:
Sreelekshmy Mohandas, Pragya D Yadav, Anita Shete, Priya Abraham, Krishna Mohan, Gajanan Sapkal, Chandrashekhar Mote, Dimpal Nyayanit, Nivedita Gupta, V K Srini, Manoj Kadam, Abhimanyu Kumar, Rajlaxmi Jain, Triparna Majumdar, Gururaj Deshpande, Savita Patil, Prasad Sarkale, Deepak Patil, Raches Ella, Sai D Prasad, Sharda Sharma, Krishna M Ella, Samiran Panda, Balram Bhargava
The availability of a safe and effective vaccine would be the eventual measure to deal with SARS-CoV-2 threat. Here, we have developed and assessed the immunogenicity and protective efficacy of an inactivated SARS-CoV-2 vaccine (BBV152) in hamsters.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::08471a05468903d4a3ae3ebea8332017
https://doi.org/10.21203/rs.3.rs-76768/v1
https://doi.org/10.21203/rs.3.rs-76768/v1
Autor:
Chetan Gadgil, Dimpal Nyayanit
Publikováno v:
RNA. 21:307-319
MicroRNAs bind to and regulate the abundance and activity of target messenger RNA through sequestration, enhanced degradation, and suppression of translation. Although miRNA have a predominantly negative effect on the target protein concentration, se